Neuro-Oncology

Updated 01.16.2024
Released 01.16.2024
Expires For CME 01.16.2027

Glioneuronal and neuronal tumors [Brief]

Authors: Pouya Jamshidi MD, Nicolas Kostelecky MD

Editor: Rimas V Lukas MD

Introduction

Key points

	• Glioneuronal and neuronal tumors are a diverse group of tumors with frequent MAPK alterations.
	• They generally have a good prognosis among the collective group of brain tumors.

Discussion

Glioneuronal and neuronal tumors are a collection of tumors that are generally low grade and show indolent behavior; many are driven by MAPK pathway alterations. They frequently occur as histologic and molecular differentials with one another, and their diagnosis requires careful integration of all relevant ancillary studies. Common clinical presentations relate to local mass effect or seizure activity.

Ganglioglioma. Gangliogliomas are MAPK pathway-driven tumors histologically notable for two cell populations: ganglion cells and glial cells. These may be closely admixed or geographically distinct within the tumor. They most often carry a BRAF V600E mutation (23) and typically arise in the temporal lobe, though they may occur anywhere (31). They carry a wide differential diagnosis of other neuroepithelial tumors, some of which are described below, with the most prominent among them being diffuse gliomas, dysembryoplastic neuroepithelial tumors, polymorphous low-grade neuroepithelial tumors of the young, and multinodular and vacuolating neuronal tumors. Additionally, focal cortical dysplasia may be in the differential diagnosis, particularly in epileptogenic cases. Overall, they have an excellent prognosis (10).

Gangliocytoma. Gangliocytomas, in contrast to the similarly named gangliogliomas described above, histologically show exclusively enlarged ganglion-like cells. Exceedingly rare, these tumors affect mostly children and may occur anywhere in the neuraxis, though, like ganglioglioma, they occur most frequently in the temporal lobe. They may also occur in the pituitary gland, where they are thought to arise through transdifferentiation from neoplastic neuroendocrine cells. Unlike ganglioglioma, they have no specific molecular alteration ascribed to them. Nonetheless, they show an excellent prognosis (31; 06).

Dysplastic cerebellar gangliocytoma. Dysplastic cerebellar gangliocytomas (ie, Lhermitte-Duclos disease) morphologically overlap with the gangliocytomas described above but have a strong association with Cowden syndrome (PTEN hamartoma syndrome) and are restricted to the cerebellar molecular and internal granular cell layers (01; 19).

Desmoplastic infantile ganglioglioma or desmoplastic infantile astrocytoma. Desmoplastic infantile ganglioglioma or desmoplastic infantile astrocytomas are benign MAPK pathway-driven tumors that occur most frequently before 24 months of age in the cerebral hemispheres. They may show a broad spectrum of morphologies, depending on the extent of the gangliocytic and astrocytic components. Both types show a desmoplastic leptomeningeal stroma, BRAF or RAF1 mutations or fusions are the most common alterations, and they have an excellent prognosis (04; 05).

Dysembryoplastic neuroepithelial tumor. Dysembryoplastic neuroepithelial tumor is an FGFR1 or BRAF V600E-driven tumor of childhood and young adulthood. Typically located in the cortex, and most frequently in the temporal lobe, these tumors have a characteristic histologic finding of “floating neurons,” normal-appearing neurons embedded in a myxoid matrix with intervening columns of oligodendroglial-like cells. Dysembryoplastic neuroepithelial tumors have a favorable prognosis (11; 30; 32; 25).

Myxoid glioneuronal tumor. Myxoid glioneuronal tumors show a near identical histologic appearance to dysembryoplastic neuroepithelial tumors, hence the original (now discouraged) name of “dysembryoplastic neuroepithelial tumor-like neoplasm of the septum pellucidum” (02). This tumor is distinctly located in the septum pellucidum, corpus callosum, or periventricular white matter and is defined by a mutation in PDGFRA. Myxoid glioneuronal tumors have a good prognosis (20).

Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters. Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters is a rare, DNA methylation-defined entity with a wide morphologic spectrum, including variable cellularity, oligodendroglioma-like cells, and multinucleated cells (24). In addition to their distinct DNA methylation profile, the monosomy of chromosome 14 is frequently described (08; 12). They are reported more frequently in children, though a broad age range has been noted. They show a favorable prognosis (12; 24; 03).

Papillary glioneuronal tumor. Papillary glioneuronal tumors are commonly supratentorial and show a predilection for young adults. They have a biphasic pattern, with a glial pseudopapillary component, cuboidal cells, and an interpapillary component of neurocytic and ganglioid cells. They show PRKCA fusions, with the most common partner being SLC44A1 (resulting in a SLC44A1::PRKCA fusion). They have a generally good prognosis (22; 15).

Rosette-forming glioneuronal tumor. Rosette-forming glioneuronal tumors are biphasic tumors composed of a rosette-forming neurocytic component and a glial component (18). They are midline in nature and often carry alterations in FGFR1, with a coinciding PIK3CA or PIK3R1 mutation (28). Though they are indolent in nature, given their typical location in the midline (eg, cerebellar vermis, 4th ventricle, and brainstem), postoperative complications are not uncommon.

Diffuse leptomeningeal glioneuronal tumor. Diffuse leptomeningeal glioneuronal tumor is a leptomeningeal-based tumor, unique in this category, which frequently shows a KIAA1549::BRAF fusion (the same as seen in pilocytic astrocytoma) (27). The affected leptomeninges can be either in the spinal cord or cerebrum. Mostly affecting pediatric patients, these tumors show a more waxing and waning clinical course as compared to other glioneuronal tumors, with variable rates of 5-year survival reported (26).

Multinodular and vacuolating neuronal tumor. Multinodular and vacuolating neuronal tumors are uncommon, cerebral-based tumors at the deep cortical ribbon or superficial white matter that harbor MAPK alterations. They have a nodular architecture with vacuolated tumor cells. They show a wide age of presentation but often have an excellent prognosis (16; 09).

Central neurocytoma and extraventricular neurocytoma. Central neurocytomas and extraventricular neurocytomas are neuroepithelial tumors with overlapping histomorphology, namely round cells with speckled chromatin. The most typical architectural finding is that of fibrillary areas, though extraventricular neurocytomas show a more diverse morphologic spectrum (14; 07). Key differences between these entities, though they share a name and some histologic findings, include their localization (intraventricular in central neurocytoma, intraparenchymal for extraventricular) and distinct molecular features. Central neurocytomas show a distinct DNA methylation profile but no other recurrent features (17). Extraventricular neurocytomas have their own separate DNA methylation profile and frequently harbor FGFR1::TACC1 fusions (29). These tumors have the potential to follow a more aggressive course than many of the entities described above.

Cerebellar liponeurocytoma. Cerebellar liponeurocytomas, as the name implies, are tumors of the cerebellum showing two morphologic populations: neurocytic cells arranged in sheets and adipocyte-like cells that are, in fact, lipid-laden neuroepithelial cells. It has a good prognosis, typically occurs in late-to-middle-aged adults, and may recur. At recurrence, the tumor may show a marked reduction in the lipid-rich cells and, in turn, may show more atypical histomorphology (21; 13).

References

01: Abel TW, Baker SJ, Fraser MM, et al. Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol 2005;64(4):341-9. PMID 15835270
02: Baisden BL, Brat DJ, Melhem ER, Rosenblum MK, King AP, Burger PC. Dysembryoplastic neuroepithelial tumor-like neoplasm of the septum pellucidum: a lesion often misdiagnosed as glioma: report of 10 cases. Am J Surg Pathol 2001;25(4):494-9. PMID 11257624
03: Benesch M, Perwein T, Apfaltrer G, et al. MR imaging and clinical characteristics of diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters. AJNR Am J Neuroradiol 2022;43(10):1523-29. PMID 36137663
04: Bianchi F, Tamburrini G, Massimi L, Caldarelli M. Supratentorial tumors typical of the infantile age: desmoplastic infantile ganglioglioma (DIG) and astrocytoma (DIA): a review. Childs Nerv Syst 2016;32(10):1833-8. PMID 27659826
05: Blessing MM, Blackburn PR, Krishnan C, et al. Desmoplastic infantile ganglioglioma: A MAPK pathway-driven and microglia/macrophage-rich neuroepithelial tumor. J Neuropathol Exp Neurol 2019;78(11):1011-21. PMID 31562743
06: Blumcke I, Spreafico R, Haaker G, et al. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med 2017;377(17):1648-56. PMID 29069555
07: Brat DJ, Scheithauer BW, Eberhart CG, Burger PC. Extraventricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol 2001;25(10):1252-60. PMID 11688459
08: Capper D, Jones DT, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature 2018;555(7697):469-74. PMID 29539639
09: Choi E, Kim SI, Won JK, et al. Clinicopathological and molecular analysis of multinodular and vacuolating neuronal tumors of the cerebrum. Hum Pathol 2019;86:203-12. PMID 30550736
10: Compton JJ, Laack NN, Eckel LJ, Schomas DA, Giannini C, Meyer FB. Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic. J Neurosurg 2012;117(5):825-30. PMID 22957524
11: Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures: report of thirty-nine cases. Neurosurgery 1988;23(5):545-56. PMID 3143922
12: Deng MY, Sill M, Sturm D, et al. Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14. Neuropathol Appl Neurobiol 2020;46(5):422-30. PMID 31867747
13: Gembruch O, Junker A, Mönninghoff C, et al. Liponeurocytoma: systematic review of a rare entity. World Neurosurg 2018;120:214-33. PMID 30205225
14: Giangaspero F, Cenacchi G, Losi L, Cerasoli S, Bisceglia M, Burger PC. Extraventricular neoplasms with neurocytoma features: a clinicopathological study of 11 cases. Am J Surg Pathol 1997;21(2):206-12. PMID 9042288
15: Hou Y, Pinheiro J, Sahm F, et al. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA. Acta Neuropathol 2019;137(5):837-46. PMID 30759284
16: Huse JT, Edgar M, Halliday J, Mikolaenko I, Lavi E, Rosenblum MK. Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion. Brain Pathol 2013;23(5):515-24. PMID 23324039
17: Imber BS, Braunstein SE, Wu FY, et al. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol 2016;126(1):193-200. PMID 26493740
18: Jacques TS, Eldridge C, Patel A, et al. Mixed glioneuronal tumour of the fourth ventricle with prominent rosette formation. Neuropathol Appl Neurobiol 2006;32(2):217-20. PMID 16599951
19: Khandpur U, Huntoon K, Smith-Cohn M, Shaw A, Elder JB. Bilateral recurrent dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) in Cowden syndrome: a case report and literature review. World Neurosurg 2019;127:319-25. PMID 30905649
20: Lucas CG, Villanueva-Meyer JE, Whipple N, et al. Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features. Brain Pathol 2020;30(3):479-94. PMID 31609499
21: Nishimoto T, Kaya B. Cerebellar liponeurocytoma. Arch Pathol Lab Med 2012;136(8):965-9. PMID 22849747
22: Pages M, Lacroix L, Tauziede-Espariat A, et al. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion. Acta Neuropathol Commun 2015;3:85. PMID 26671581
23: Pekmezci M, Villanueva-Meyer JE, Goode B, et al. The genetic landscape of ganglioglioma. Acta Neuropathol Commun 2018;6(1):47. PMID 29880043
24: Pickles JC, Mankad K, Aizpurua M, et al. A case series of Diffuse glioneuronal tumours with oligodendroglioma-like features and nuclear clusters (DGONC). Neuropathol Appl Neurobiol 2021;47(3):464-7. PMID 33325069
25: Qaddoumi I, Orisme W, Wen J, et al. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 2016;131(6):833-45. PMID 26810070
26: Rodriguez FJ, Perry A, Rosenblum MK, et al. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol 2012;124(5):627-41. PMID 22941225
27: Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A. High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol 2015;129(4):609-10. PMID 25720745
28: Sievers P, Appay R, Schrimpf D, et al. Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1. Acta Neuropathol 2019;138(3):497-504. PMID 31250151
29: Sievers P, Stichel D, Schrimpf D, et al. FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma. Acta Neuropathol 2018;136(2):293-302. PMID 29978331
30: Stanescu Cosson R, Varlet P, Beuvon F, et al. Dysembryoplastic neuroepithelial tumors: CT, MR findings and imaging follow-up: a study of 53 cases. J Neuroradiol 2001;28(4):230-40. PMID 11924137
31: Thom M, Blümcke I, Aronica E. Long-term epilepsy-associated tumors. Brain Pathol 2012;22(3):350-79. PMID 22497610
32: Thom M, Toma A, An S, et al. One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol 2011;70(10):859-78. PMID 21937911
33: References especially recommended by the author or editor for general reading.

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Glioneuronal and neuronal tumors …

Glioneuronal and neuronal tumors [Brief]

Introduction

Key points

Discussion

References

Contributors

Authors

Editor

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Atypical teratoid/rhabdoid tumors

Astrocytoma IDH mutant, WHO grade 2

Neoplastic and infectious aneurysms

Spinal meningioma

Dermoid and epidermoid tumors

Leukemia: neurologic complications

Pediatric-type diffuse high-grade gliomas [Brief]

Glioneuronal and neuronal tumors [Brief]

Introduction

Key points

Discussion

References

Contributors

Authors

Editor

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Atypical teratoid/rhabdoid tumors

Astrocytoma IDH mutant, WHO grade 2

Neoplastic and infectious aneurysms

Spinal meningioma

Dermoid and epidermoid tumors

Leukemia: neurologic complications

Pediatric-type diffuse high-grade gliomas [Brief]

This is an article preview.
Start a Free Account
to access the full version.